Pharmaceutical giant Pfizer announced today it will be eliminating 300 manufacturing jobs by the end of 2015 at its Andover, MA, biotech plant, as part of a restructuring plan following its $68 billion acquisition of New Jersey-based Wyeth (NYSE: [[ticker:WYE]]) last year. Pfizer will be cutting about 6,000 jobs over the next few years, by shutting down eight sites and reducing headcount at another six plants worldwide, in order to increase the efficiency in its manufacturing processes, the announcement said. The job cuts will leave Pfizer with about 2,000 employees in Massachusetts, including its two locations in Cambridge.
Author: Erin Kutz
Erin Kutz has a background in covering business, politics and general news. She holds a bachelor’s degree in journalism from Boston University. Erin previously worked in the Boston bureau of Reuters, where she wrote articles on the investment management and mutual fund industries. While in college, she researched for USA Today reporter Jayne O’Donnell’s book, Gen Buy: How Tweens, Teens and Twenty-Somethings Are Revolutionizing Retail. She also spent a semester in Washington, DC, reporting Capitol Hill stories as a correspondent for two Connecticut newspapers and interning in the Money section of USA Today, where she assisted with coverage on the retail and small business beats. Erin got her first taste of reporting at Boston University’s independent student newspaper, as a city section reporter and fact checker and editor of the paper’s weekly business section.
View all posts by Erin Kutz
